WallStreetZenWallStreetZen

NASDAQ: ADVM
Adverum Biotechnologies Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ADVM past revenue growth

How has ADVM's revenue growth performed historically?
Company
N/A
Industry
145.73%
Market
17.2%
ADVM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADVM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ADVM earnings and revenue history

Current Revenue
$3.6M
Current Earnings
-$117.2M
Current Profit Margin
-3,254.6%

ADVM Return on Equity

Current Company
-98.6%
Current Industry
-63.5%
Current Market
188%
ADVM's Return on Equity (-98.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADVM announces earnings.

ADVM Return on Assets

Current Company
-52.8%
Current Industry
2.9%
ADVM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADVM Return on Capital Employed

Current Company
-79.84%
Current Industry
19.5%
ADVM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADVM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADVM$3.60M-$99.57M-$117.17M+17.43%N/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
ZVRA$27.46M-$43.54M-$46.05M+20.93%N/A
IPHA$67.00M-$700.00k-$8.23M-8.70%N/A
RIGL$116.88M-$16.98M-$25.09M+21.30%N/A
View Top Biotech Stocks

ADVM earnings dates

Next earnings date
May 9, 2024

Adverum Biotechnologies Earnings & Revenue FAQ

What were ADVM's earnings last quarter?

On Invalid Date, Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 2023 earnings per share (EPS) of -$2.30, up 30.3% year over year. Total Adverum Biotechnologies earnings for the quarter were -$23.71 million. In the same quarter last year, Adverum Biotechnologies's earnings per share (EPS) was -$3.30.

If you're new to stock investing, here's how to buy Adverum Biotechnologies stock.

What was ADVM's earnings growth in the past year?

As of Q2 2024, Adverum Biotechnologies's earnings has grown year over year. Adverum Biotechnologies's earnings in the past year totalled -$117.17 million.

What is ADVM's earnings date?

Adverum Biotechnologies's earnings date is Invalid Date. Add ADVM to your watchlist to be reminded of ADVM's next earnings announcement.

What was ADVM's revenue last quarter?

On Invalid Date, Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Adverum Biotechnologies's revenue was $0.00.

What was ADVM's revenue growth in the past year?

As of Q2 2024, Adverum Biotechnologies's revenue has grown null year over year. Adverum Biotechnologies's revenue in the past year totalled $3.60 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.